APA Zitierstil

Baselga, J., Morales, S. M., Awada, A., Blum, J. L., Tan, A. R., Ewertz, M., . . . Rugo, H. S. (2017). A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer. Breast Cancer Res Treat.

Chicago Zitierstil

Baselga, José, et al. "A Phase II Study of Combined Ridaforolimus and Dalotuzumab Compared With Exemestane in Patients With Estrogen Receptor-positive Breast Cancer." Breast Cancer Res Treat 2017.

MLA Zitierstil

Baselga, José, et al. "A Phase II Study of Combined Ridaforolimus and Dalotuzumab Compared With Exemestane in Patients With Estrogen Receptor-positive Breast Cancer." Breast Cancer Res Treat 2017.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.